Evotec (EVO) Stock
Evotec (EVO) closed at $1.56 on Nov 16, 2026; its Tenet Score is 51 of 100 against 409 Healthcare peers.
Key stats
- Previous close
- $1.56
- Nov 16, 2026
- Market cap
- $554.7M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 1.33 – 3.87
- low → high
- Tenet Score
- 51/100
- Mixed · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Evotec SE scores 51/100. Mixed. Strongest on value, financial health is the soft spot versus 409 Healthcare peers.
Tenet Score · vs sector
n=409Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ~ Piotroski F-Score
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
- ✕ Not-a-Value-Trap Gate
13F flows & insider trades land here.
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosi…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Immix Biopharma IncIMMX | 69 | $657.1M |
| Arbutus Biopharma CorpABUS | 49 | $627.0M |
| Geron Corp.GERN | 56 | $623.0M |
| Wave Life Sciences Inc.WVE | 54 | $617.3M |
| Pacific Biosciences of California, IncPACB | 40 | $613.3M |
| Climb Bio Inc.CLYM | 62 | $608.5M |
| Sana Biotechnology IncSANA | 34 | $605.3M |
| Capricor Therapeutics IncCAPR | 51 | $554.1M |
| Phathom Pharmaceuticals, Inc.PHAT | 33 | $492.6M |
| Candel Therapeutics IncCADL | 45 | $486.4M |
Common questions
What sector and industry is Evotec in?
Evotec is in the Healthcare sector and the Drugs industry.
What is Evotec's Tenet Score?
Evotec's Tenet Score is 51 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




